|Year : 2018 | Volume
| Issue : 1 | Page : 44-47
Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center
Parvan A Shetty, Mitesh R Maurya, Brinal H Figer, Urmila M Thatte, Nithya J Gogtay
Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
|Date of Web Publication||25-Jan-2018|
Dr. Nithya J Gogtay
Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra
Source of Support: None, Conflict of Interest: None
| Abstract|| |
The quality of the written informed consent process is one of the most important aspects of clinical research, as it is the single tool that serves as a metric of autonomy. Several challenges have been identified with the informed consent process in developing countries the most important of which is the ability to assimilate and understand the information presented in the consent form. In India, a unique aspect of the informed consent process is the need for audio-video [AV] recording of the process for vulnerable populations and new chemical entities. The present narrative summates authors' experiences as investigators with A-V recording of the informed consent process as also providing a brief narrative review of relevant literature. It also offers potential solutions for challenges faced during this process.
Keywords: Adequacy of consent, investigators' responsibilities, regulatory requirements for consent in India
|How to cite this article:|
Shetty PA, Maurya MR, Figer BH, Thatte UM, Gogtay NJ. Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center. Perspect Clin Res 2018;9:44-7
|How to cite this URL:|
Shetty PA, Maurya MR, Figer BH, Thatte UM, Gogtay NJ. Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center. Perspect Clin Res [serial online] 2018 [cited 2022 Jun 29];9:44-7. Available from: https://www.picronline.org/text.asp?2018/9/1/44/223942
| Introduction|| |
The quality of the written informed consent process is one of the most important aspects of clinical research, as it is the single tool that serves as a metric of autonomy. In emerging economies, many challenges have been identified that make the informed consent process difficult. An important challenge is the ability to comprehend and assimilate information present in the consent form for a wide variety of reasons.
In response to a petition filed by an Indore-based group regarding the conduct of clinical trials in India, on October 21, 2013, a directive from the Supreme Court of India mandated audiovisual (A-V) recording of the informed consent process for all trials. The Central Drugs Standard Control Organization (CDSCO) together with the Drugs Technical Advisory Board [DTAB] then issued an order on November 19, 2013, that, in all clinical trials, in addition to obtaining written informed consent, A-V recording of the informed consent process of each trial participant is necessary. This was done as a necessary step toward implementing the Supreme Court Directive. The original order was subsequently modified (July 31, 2015 [G. S. R. 611(E)]), making A-V consent mandatory only in cases of vulnerable populations and with research on new chemical entities.
Against this backdrop, the present narrative summates authors' experiences as investigators with A-V recording of the informed consent process. It includes both personal experiences as also published literature on the subject (both by the authors and other investigators) which may be of value to trialists in India.
| A Brief Narrative Review of Literature|| |
Will audio-visual recording of the informed consent process be accepted by trial participants?
A-V recording of the informed consent process is expected to serve as a means to better document understanding by potential participants. It also serves as a legal record for the investigator regarding the information provided to the participant in detail and can act as an effective tool for the sponsor, ethics committees, or regulators during the processes of monitoring, auditing, or inspections. While improvement in the quality of the conduct of the informed consent process and transparency can be viewed as potential advantages of A-V consenting, the process can present significant challenges. Chauhan et al. carried out a descriptive survey among 150 residents of rural South India to assess the acceptability of A-V recording with a hypothetical scenario of a clinical study. Once written informed consent was obtained, participants were asked whether they would consent for A-V recording. It was seen that 34% of those who gave written informed consent, declined A-V consenting for a variety of reasons.
Does audio-visual recording of the informed consent process actually improve understanding and comprehension of information?
At the point of the issue of the administrative order by the CDSCO in November 2013, a clinical trial (CTRI/2012/05/002709) investigating an antirabies monoclonal antibody was ongoing at our center. Forty-five patients had thus far been recruited after they gave written, informed consent. Subsequent to the notification that mandated A-V recording of the consent process, n = 40, more patients were enrolled all of whom underwent A-V recording of the informed consent process. In view of the fact that a single study fortuitously had participants who had undergone both consenting processes, the authors evaluated whether there was a difference in understanding between the two consenting processes using a 16-item validated questionnaire. A total of 21 patients in the A-V consent group and 17 patients in the written informed consent group (who consented) completed the questionnaire. The total score (mean ± standard deviation) in the A-V consent group was significantly higher relative to the written, informed consent group (40.3 ± 5.9 vs. 34.8 ± 7.9; P = 0.01). With the A-V consent group, the total score was significantly higher in the domain of rights and confidentiality (P = 0.01). Furthermore, proportion of participants who gave fully correct answers in the domain of purpose were higher in the former group (paper accepted for publication; National Medical Journal of India).
| Challenges Faced by Investigators during the A-V Recording of the Informed Consent Process and Potential Solutions – a Personal Narrative|| |
The challenges listed below are those faced by the investigator's team as also those identified by the Institutional Ethics Committee (IEC) during their monitoring of the site. The challenges are outlined. Both challenges and solutions are presented in [Table 1]. All challenges can actually be addressed by using detailed standard operating procedures (SOPs) and training of the study team members.
|Table 1: Challenges faced during the audiovisual recording of the informed consent process and potential solutions|
Click here to view
Operational challenges during the recording process
Both poor sound and poor visual quality can be found once the A-V consent is completed. This was found by the IEC during its monitoring. In addition, the IEC monitoring also found that the physician carrying out the consent, the patient or the legally acceptable representative was often not seen in the video frame, nor was the final signature process not seen.
Challenges regarding the total duration of the consent process
Most sponsors' monitors and IEC members at the time of monitoring/inspection view the duration of the consent process as a metric of adequacy of the consent process. This is almost never stated in their SOPs or mentioned at site initiation visits. Based on experience, they insist on 45 min to an hour for each consent. However, even before the start of the A-V recording, an investigator always explains the basic aspects of the trial and the various procedures to be done to the participant. Second, we have seen that participants often fidget or get restless or even switch off mentally when these aspects are repeated and reiterated during the A-V recording. Thus, even if the recording time is just 20 min or thereabouts, the actual process of consenting is much longer, and this needs to be borne in mind by both sponsors and IEC members.
When neonates and infants are participants
During an IEC monitoring of A-V consents done by us for a particular study done by us (that involved neonates and infants), the IEC insisted on the neonate/infant being present with the parent and be seen in the video frame at all times. This may not always be possible with a sick or irritable child. The parent has freedom and the ability to pay attention to the A-V consent when the child is with a relative or in the vicinity and visible to the parent at all times. A crying or a sick child also can preclude A-V consent and prompt refusal and this needs to be borne in mind for pediatric studies.
Testing the participants' understanding
One of the aspects insisted upon by both IEC as well as sponsors is assessing the understanding/comprehending the information in the consent form. The process of A-V consenting, at least in during the first few times, is also fairly stressful for the physician taking the consent and this assessment is often forgotten.
Training of study personnel
Study team members delegated the responsibility of the A-V consent process need training in it through mock/dry runs. The training should involve the use of checklists as the consenting process can be equally stressful for the novice members. This needs to be followed up by real-time monitoring and supervision by members experienced in A-V consenting.
Storage, archival, and retrieval
All the study team members involved in taking A-V consent of the participant should be aware about the storage of the video files. All the videos should be saved in external hard drives, Compact discs, or a cloud-based storage system in a coded format (as per site/sponsor SOPs) to prevent misuse and protect the identity and confidentiality of the study participants. Furthermore, it should be made sure that the video files are deleted immediately from the recording device. The Principal Investigator should take special care pertaining to the protection of the identity of the participants and make sure that only the site staff delegated the responsibility of storage, archival, and retrieval of the A-V recording have access to the video recordings.
| Other Challenges|| |
The authors work in a tertiary referral center in a metropolitan city. It is likely that given the cultural diversity that exists in the country, there may be many more challenges during the process of A-V consenting. These have been eloquently summarized by Kulkarni et al. and include inadequate infrastructure (for example, a separate room for consent may be difficult in many places), cultural sensitivity (women unwilling to consent due to a male physician or use of a head scarf/veil during the consenting process that may mask the face), lack of willingness to discuss ailments on camera, language barriers that make the dialog between the physician and participant difficult, and cost considerations both for the sponsor and investigator to set up and effectively carry out the A-V consenting.
| Conclusions|| |
The process of A-V recording of the consent process was established in an attempt to improve and strengthen the written informed consent process. Its implementation is, however, fraught with challenges, some of which we have tried to address. All stakeholders (investigators, sponsors, regulators, and ethics committees) in research need to jointly work together to ensure that the process of A-V recording of the consent process fulfills the very reason that it was established in the first place – greater participant protection.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ghooi RB. How informed are our subjects? Perspect Clin Res 2016;7:109-10.
] [Full text]
Kulkarni NG, Dalal JJ, Kulkarni TN. Audio-video recording of informed consent process: Boon or bane. Perspect Clin Res 2014;5:6-10.
] [Full text]
Chauhan RC, Purty AJ, Singh N. Consent for audio-video recording of informed consent process in rural South India. Perspect Clin Res 2015;6:159-62.
] [Full text]
Figer BH, Chaturvedi M, Thaker SJ, Gogtay NJ, Thatte UM. A comparative study of the informed consent process with or without audio-visual recording. Natl Med J India. [In Press].
|This article has been cited by|
||What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesis
| ||Sangeetha Paramasivan,Philippa Davies,Alison Richards,Julia Wade,Leila Rooshenas,Nicola Mills,Alba Realpe,Jeffrey Pradeep Raj,Supriya Subramani,Jonathan Ives,Richard Huxtable,Jane M Blazeby,Jenny L Donovan |
| ||BMJ Global Health. 2021; 6(5): e004729 |
|[Pubmed] | [DOI]|
||Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators’ perspective
| ||Sindhu Sivanandan,Kajal Jain,Nishad Plakkal,Monika Bahl,Tanushree Sahoo,Shirshendu Mukherjee,Yogendra Kumar Gupta,Ramesh Agarwal |
| ||Journal of Perinatology. 2019; 39(S1): 20 |
|[Pubmed] | [DOI]|
||Cultural considerations for informed consent in paediatric research in low/middle-income countries: a scoping review
| ||Marcela Colom,Peter Rohloff |
| ||BMJ Paediatrics Open. 2018; 2(1): e000298 |
|[Pubmed] | [DOI]|